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Abstract
Background: understanding the determinants of health burden after a fracture in ageing populations is important.
Objective: assess the effect of clinical vertebral and other osteoporotic fractures on function and the subsequent risk of
hospitalisation.
Design: individuals from the prospective population-based cohort study Age, Gene/Environment Susceptibility (AGES)-
Reykjavik study were examined between 2002 and 2006 and followed up for 5.4 years.
Subjects: a total of 5,764 individuals, 57.7% women, born 1907–35, mean age 77.
Method: four groups with a veriﬁed fracture status were used; vertebral fractures, other osteoporotic fractures excluding
vertebral, non-osteoporotic fractures and not-fractured were compared and analysed for the effect on mobility, strength,
QoL, ADL, co-morbidity and hospitalisation.
Results: worst performance on functional tests was in the vertebral fracture group for women (P < 0.0001) and the other
osteoporotic fractures group for men (P < 0.05). Both vertebral and other osteoporotic fractures, showed an increased risk
of hospitalisation, HR = 1.4 (95% CI: 1.3–1.7) and 1.2 (95% CI: 1.1–1.2) respectively (P < 0.0001). Individuals with verte-
bral fractures had 50% (P < 0.0001) longer hospitalisation than not-fractured and 33% (P< 0.002) longer than the other
osteoporotic fractures group.
Conclusion: individuals with a history of clinical vertebral fracture seem to carry the greatest health burden compared with
other fracture groups, emphasising the attention which should be given to those individuals.
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Introduction
Osteoporotic fractures have a major impact on global
public health [1]. Fractures are one of the most common
causes of disability and represent a considerable cost in
the health care system [2]. In ageing populations, an
understanding of the determinants of a decline in func-
tion after these fractures may be important for reducing
costs and improving quality of life (QoL). However, the
literature has mostly focused on the epidemiology and
health care burden of hip fractures, reﬂecting the high
individual hospital cost, the personal burden of these
fractures in terms of limited mobility and the ease of
identifying these fractures since treatment generally
requires hospitalisation. On the other hand, since hip
fractures represent less than 50% of all fractures even in
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the elderly over 80 years of age, the burden of other
osteoporotic fractures might be underestimated [3, 4].
Research into the epidemiology of other clinical fractures
is then necessary to develop a better understanding of
the health burden, hospitalisation and determinants of
decline of function after fracture [5].
Vertebral fractures (Vfrs) are the most frequent compli-
cation of osteoporosis and incident clinical Vfrs were esti-
mated to have affected 1.4 million individuals worldwide in
2000 [6]. The lifetime risk of sustaining a Vfr is 15.4% for
women older than 45 years and 8.6% for men [7]. The
prevalence of these fractures increase with age among both
sexes [8]. Vfrs are signiﬁcantly under-reported [9] and the
personal burden of these fractures may therefore be
underestimated.
Only a few studies have addressed the question of whether
or not Vfrs are associated with other key outcomes including
hospitalisation [10, 11] with the increased cost of health care
[12]. It is important to obtain better information on the health
burden of vertebral and other osteoporotic fractures [5] for the
potential of preventive interventions.
The population-based Ages Gene/Environment
Susceptibility (AGES)-Reykjavik study [13] gives a unique
opportunity to examine the health burden of those who have
suffered fractures as well as the epidemiological association
with factors that may make it possible to improve such things
as mobility, strength, activities of daily living (ADL) and QoL.
Methods
Participants
The AGES-Reykjavik study is an extension of the population-
based Reykjavik study which started in 1967 [14, 15].
Participants were invited for examinations through 1996 with a
response rate of 71.8%. In 2002, survivors of the Reykjavik
study, a total of 8.030 participants, were randomly selected and
invited, and 5,764 agreed to participate; of these 457 were
excluded as they did not have functional measurements or did
not give permission to connect their data with their hospital
ﬁles (n= 18). Recruitment into the study was carried out
between September 2002 and January 2006. Participants were
grouped into one of four mutually exclusive groups: (i) Vfrs,
may have had other fractures (Ofrs), (ii) other osteoporotic site
fractures excluding vertebral (oOSfr), (iii) Ofrs not osteoporotic
site and (iv) not-fractured (Nfr) (Figure 1).
Fractures
Fracture data were ascertained from the Reykjavik study
fracture registry and veriﬁed by medical and radiological
Figure 1. Flow chart of timeline and participants categorised by sex and previous fractures. Fractures sustained before the entry
into the AGES-Reykjavik Study were recorded, veriﬁed and conﬁrmed from medical and radiological records as described [16].
The following were deﬁned as osteoporotic sites: vertebral (S12.1, S12.2, S22.0, S22.1, S32.0, T08), pelvic (S32.1, S32.3, S32.4,
S32.5), proximal humerus (S42.2, S42.4), distal forearm (S52.5, S52.6), hip (S72.0, S72.1, S72.2), proximal tibia (S82.1).
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records from 1966 to 2006 [16]. The fracture status used in
the study was recorded at the participant’s entry into the
AGES-Reykjavik study 2002–06. Osteoporotic site fractures
were deﬁned according to ICD10 diagnostic codes.
Baseline examination
ADL was assessed by asking the participants how difﬁcult
it was to: dress, eat, bathe, transfer out of bed/chair or
walk from room to room. A score of 0–5 was given with a
greater score associated with dependency. Health-related
QoL was assessed by EQ-5D, [17] where lower score was
associated with poorer outcome. Basic mobility deﬁned as
the result of a Timed Up and Go test [18, 19] and a six-
metre walk test [20]. Strength was measured by a maximal
isometric muscle strength of the hand and quadriceps [21].
Co-morbidity and hospitalisation
Information of the participant’s ﬁrst hospital admission,
diagnosis (ICD10 code) and duration were obtained from
the database of Landspitalinn University Hospital, the main
hospital in Reykjavik. The hospitalisations were grouped
into nine mutually exclusive groups using the diagnostic
codes in Supplementary data are available in Age and Ageing
online, Table S1 from the participant’s entry into the
AGES-Reykjavik study until 31 December 2009. The
Charlson score was used to assess co-morbidity [22].
Statistical analyses
Functional outcomes and QoL measures were compared by
sex according to subgroups deﬁned from fractures status.
General linear models were used with adjustment for age
and a four-level categorical predictor for fracture status.
The assumption of normally distributed residuals was
inspected graphically using normal quantile plots. The six-
metre walk and the Timed Up and Go variables were log-
transformed. A comparison of the relative effect of fracture
on function and strength outcomes (normalised for thigh
length) between men and women was made by analysing
men and women together using log-transformed outcomes
with an interaction term for sex. The effect of fracture on
function was analysed by dividing fracture status into two
groups; fracture within 10 years before entry into the study
and more than 10 years before entry.
The time to ﬁrst hospital admission after entry into the
study was analysed using the Cox proportional hazards re-
gression model, by sex with age adjustment and a four-level
categorical predictor for fracture status. Analyses were done
with and without adjustment for mobility, strength and
co-morbidity. Men and women were also analysed together
and interaction between sex and fractures status was tested
using a product term in the regression model.
The survival analysis of hospital admissions was also
performed by estimating the effect of fracture by time since
the fracture occurred before entry into the study (within 10
years or more than 10 years).
The proportional hazards assumption was assessed
graphically (log(-log(survival)) versus log(time)) and tested
formally using the cox.zph function of the survival package
in R version 2.10.1. Violations from proportionality were
not found to be signiﬁcant, neither visually or statistically.
The duration of hospitalisation was analysed for the
individuals with hospital admission by a Poisson regression
model with log-length of follow-up as an offset. The ana-
lysis was performed separately by sex with age adjustment
and fracture status as an explanatory variable.
The Charlson score was analysed using a four level
response variable: (i) A score of 0, (ii) a score of 1, (iii) a
score of 2–5, (iv) a score higher than 5. A proportional
odds polytomous regression model with a generalised logit
link was used to test for signiﬁcant association with fracture
status and interaction between sex and fracture status. The
model included adjustment for age. SAS/STAT version
8.02 and R version 2.10.1 was used to analyse the data.
Results
There were 5,307 participants with baseline functional mea-
surements available for the analysis (Figure 1), 3,029
women (57%) with a mean age of 76 years (range 66–95)
and 2,278 men (43%) with a mean age of 77 years (range
67–96). The prevalence at entry into the study of clinical
Vfrs increased with age in both sexes. It was signiﬁcantly
higher in women (P< 0.0001). The prevalence peaked at
13.2% in the oldest age group (>85 years) for women
but levelled off in men at 3.5% at the age of 80 years
(Supplementary data are available in Age and Ageing online,
Figure S1).
Functional capability and quality of life
Table 1 shows function and QoL by fracture status at entry
into the study. Having sustained a fracture was generally
associated with a worse performance and QoL. Women
with Vfr had signiﬁcantly poorer performance and self-
reported function compared with Ofr groups and Nfr
(P ≤ 0.01). For men with Vfr poorer performance was
seen for quadriceps-strength, mobility (TUG) and ADL
(P < 0.01). A previous oOSfr had an effect both in men
and women, but more clearly seen in men.
The difference in the relative effect of fracture status on
function between men and women was found to be insig-
niﬁcant for strength, TUG and ADL. In the case of the
six-metre walk and QoL, women had signiﬁcantly worse
result than men (P < 0.05). Adjustment for the prevalence
of hip fractures did not change the estimated effect of
fractures on TUG, strength and ADL.
The time since fracture impacted the participants func-
tion and QoL. Compared with Nfr, those who fractured
less than 10 years ago had worse function than those who
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Test of difference between fractures and control group P-valuesa



















Grip strength, average (kg) 39.4 9.5 39.4 9.9 36.8 8.9 36.7 8.2 — –— 0.002 — 0.03 —
Quadriceps strength, average (kg) 41.3 11.1 40.6 11.0 38.3 10.8 37.7 10.0 — 0.02 0.001 — — 0.02
Timed Up and Go, average (s)b 12.2 3.2 12.6 3.6 12.8 3.8 13.3 3.8 — 0.04 — — — 0.01
Six-metre walk, average (s)b 6.48 1.94 6.64 2.06 6.86 2.13 6.84 1.87 — — 0.03 — — 0.01
Activity of daily living 0.33 0.77 0.36 0.81 0.5 1.01 0.64 1.16 — 0.003 0.02 0.02 — —
EQ-5D score 0.88 0.16 0.87 0.17 0.83 0.18 0.85 0.17 — — 0.001 — — —
Women
Grip strength, average (kg) 24.2 5.9 24.0 6.1 22.9 5.6 21.3 5.3 0.002 <0.0001 0.02 0.0002 — —
Quadriceps strength, average (kg) 26.7 7.7 26.5 8.3 25.6 7.5 22.6 7.02 <0.0001 <0.0001 — <0.0001 — —
Timed Up and Go, average (s)b 12.4 3.7 12.4 3.7 13.2 4.2 14.3 5.6 0.01 <0.0001 0.02 <0.0001 0.02 —
Six-metre walk, average (s)b 6.88 1.95 6.79 1.77 7.21 2.09 7.72 2.34 0.005 <0.0001 — <0.0001 0.02 —
Activity of daily living 0.48 0.96 0.51 0.96 0.58 1.09 0.86 1.34 0.001 <0.0001 — 0.001 — —
EQ-5D score 0.81 0.2 0.78 0.21 0.8 0.2 0.72 0.25 <0.0001 <0.0001 — 0.003 — 0.03
—, Not significant.
aComparisons are adjusted for age.








fractured more than 10 years ago (Supplementary data are
available in Age and Ageing online, Table S3).
Co-morbidity and hospitalisation
During the follow-up with a median of 5.4 years (inter-
quartile range 4.7–6.3), 3,457 (65%) participants were hos-
pitalised at least once; 68% men and 63% women. For
men, the percentages hospitalised by fracture status were
Vfr 82; oOSfr 70; Ofr 69 and not-fractured 67%. For
women, Vfr 76; oOSfr 68; Ofr 63 and Nfr 58%.
The most common hospital diagnoses (80%), during
follow-up, were the same in the fracture group as in the
Nfr group; atrial ﬁbrillation, coronary heart disease, pneu-
monia, cancer, osteoporotic fracture, digestive system dis-
eases, muscoskeletal and genitourinary system. After
adjustment for age, sex, TUG, quadriceps-strength and
Charlson score, the risk of hospitalisation was still greater
for those with previous fracture (Figure 2). Generally the
Vfr group was worse off depending on the hospital diagno-
sis; the risk (HR) for a new osteoporotic fracture was 2.7
(95% CI: 2.0–3.6), musculoskeletal diseases HR1.9 (95%
CI: 1.5–2.3), pneumonia HR 1.5 (95% CI: 1.1–2.0) and
genitourinary diseases HR 1.3 (95% CI: 1.0–1.7). On the
other hand, the oOSfr group was only hospitalised more
often because of a new osteoporotic fracture compared
with the Nfr after adjustment for confounders.
To examine if hospitalisation was inﬂuenced by the time
since fracture occurred, individuals with fractures were
grouped into subgroups; those sustaining fracture less or
more than10 years ago (Supplementary data are available in
Age and Ageing online, Table S2). A greater risk of
hospitalisation was seen in the group with the shorter time
since the last fracture, especially in the Vfr group. Relative
to the Nfr group, the Vfr group had HR of 1.4 (95% CI:
1.2–1.6 (P = 0.0002)), the oOSfr; HR1.2 (95% CI: 1.1–1.4
(P = 0.001)); the Ofr; HR1.2 (95% CI: 1.2–1.3 (P = 0.02)).
The HR for the Vfr group that had fractured more than 10
years ago was 1.2 (95% CI: 1.0–1.6 (P =NS)), the oOSfr;
HR1.2 (95% CI: 1.0–1.3 (P = 0.02)), the Ofr; HR1.2
(95% CI: 0.9–1.2 (P=NS)). Adjustment was made for age,
sex, six-metre walk, quadriceps-strength and co-morbidity.
Individuals with Vfr had an average 50% (95% CI:
27–77% (P < 0.0001)) longer stay in hospital than those
with Nfr and 33% (95% CI: 11–60% (P = 0.005)) longer
than the oOSfr group. Men without previous fractures had
the shortest hospital stay, on average/year, 6.5 days (range
6.6–7.7) but men in the Vfr group had the longest, 12.7
days, (range 12.3–13.0). Generally, individuals with Vfr had
more co-morbidity than Nfr (P = 0.005) and men were
more often hospitalised and had longer hospital stay than
women with Vfr (P < 0.0001).
Discussion
This population-based study of elderly men and women,
with 5.4 years of follow-up, indicates that individuals with
Vfr were associated with a greater health burden than those
with other osteoporotic fractures. This was shown by more
co-morbidity, hospitalisations and longer hospital stay for
both sexes in those with previous Vfrs in comparison with
Nfr and Ofr groups. Men were signiﬁcantly worse off than
women and a shorter time since fracture, increased the risk
of worse function and hospitalisation.
Figure 2. The 80% of the most common hospital diagnosis according to the study groups. Hazard ratios (95% CI) of clinical
vertebral and other fractures group compared with the control group. Adjustment made for age and sex, quadriceps strength, six-
metre walk and co-morbidity. Vfr: vertebral fracture, oOSfr: osteoporotic fracture excluding vertebral, Ofr, fracture excluding all
osteoporotic fracture; Nfr, not-fractured.
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Our elderly men with fractures seem to represent an
especially frail part of the population. The increased risk of
hospitalisation in the fracture groups of men as well as the
high co-morbidity, especially in the vertebral group, sup-
ports this. We observed that pneumonia and muscoskeletal
system diseases were signiﬁcantly increased in the post-Vfr
group. The former may be caused by impaired chest func-
tion and the latter, because of a possible increased use of
pain killers.
Our results conﬁrm the increased prevalence of Vfr
with increasing age and the expected difference between
the sexes previously reported [4]. However, our study
shows the prevalence to level out in the oldest age groups
of men. The reason might be an effect of survival but it
has previously been shown that individuals suffering from
Vfrs have high mortality risk [23]. This may have been
more pronounced in our vertebral group of men as men
have been shown to have a higher rate of fracture-related
mortality compared with women [24, 25] which might
reﬂect a poor health status.
Tests like muscle strength and mobility such as the six-
metre walk, Timed Up and Go which measure the actual
physical performance enhance our understanding of the
impact of previous fractures on the individual’s body func-
tion. These objective measurements have been used in an
epidemiological context to examine fracture risk and appear
to be of importance [26]. These measurements have also
been used to measure functional recovery after hip fractures
and it has been recognised that many individuals do not
achieve their pre-fracture level of function 1 year after a
fracture [27]. Similar information on Vfrs is scarce. Our
results showed that the relative effect size of a clinical Vfr
on function performance to be mostly similar in both sexes
even though women had an overall worse function than
men. A possible explanation might be that baseline absolute
values are higher in men as well as the skeletal muscle
fatigue resistance [28]. The fact that osteoporotic fractures,
other than Vfr had more impact on men than women
might reﬂect poorer health in the men who survive a pelvic
or hip fracture.
The results from the QoL measurements showed that
women were signiﬁcantly worse off than men. A partial ex-
planation might be that women are known to rate their
QoL lower than men [29] and do have more clinical frac-
tures as well as twice the amount of morphometric deform-
ities in the spine than come to clinical attention [9]. These
silent fractures are not without symptoms [30] and may
therefore be of clinical signiﬁcance.
Our study has several strengths but also limitations.
This is a population representative study of free-living
elderly people, including both sexes from a large veriﬁed
fracture registry. The study is prospective for hospitalisa-
tion, but the functions were only measured at entry and not
assessed again during the follow-up. The main weakness
consists of a potential selection bias caused by non-
responders who are likely to be sicker and may have more
of deleterious fractures such as hip fractures and not make
it to the study. However, although this may underestimate
the total effect of fractures on function and hospitalisation,
it should not affect the importance of this study results
with respect to the impact of fracture on the participant’s
function and hospitalisation.
In conclusion, this study adds important information
on the consequences of osteoporotic fractures in older
people. Individuals with these fractures have diminished
performance in all functional tests, a worse QoL, more
co-morbidity and a greater need of hospitalisation as well
as longer hospital stays. This group of elderly people with a
history of Vfr needs special attention to maintain their
function and prevent further hospitalisations.
Key points
• Knowledge is missing if an impact of Vfrs on the indivi-
dual’s health differs from other osteoporotic fractures.
• Individuals with history of Vfrs carried more of a health
burden than individuals with other osteoporotic fractures.
• This was reﬂected in signiﬁcantly increased co-morbidity,
more hospitalisations and longer hospital stays.
• Men with previous history of Vfr had signiﬁcantly more
of a health burden than women.
• Time since fracture impacts the individuals function, hos-
pitalisation and QoL.
Acknowledgements
We are grateful to Olafur Grimur Bjornsson, MD. PhD
and David Vilmundarson for helpful comments on the
manuscript and to the staff of the Icelandic Heart




Informed consent was obtained and the study was reviewed
and approved by the National Bioethics Committee in
Iceland (VSN 00-063) and the National Institute on Aging
Intramural Institutional Review Board.
Funding
This study was funded by the National Institutes of Health,
USA contract N01-AG-12100, the National Institute on
Aging Intramural Research Program, Hjartavernd (The
Icelandic Heart Association) and the Althingi (The
Icelandic Parliament).
356
K. Siggeirsdottir et al.
Supplementary data
Supplementary data mentioned in the text is available to
subscribers in Age and Ageing online.
References
1. Cole ZA, Dennison EM, Cooper C. The impact of methods
for estimating bone health and the global burden of bone
disease. Salud Publica Mex 2009; 51(Suppl. 1): S38–45.
2. Cummings SR, Melton LJ. Epidemiology and outcomes of
osteoporotic fractures. Lancet 2002; 359: 1761–7.
3. Jones G, Nguyen T, Sambrook PN, Kelly PJ, Gilbert C,
Eisman JA. Symptomatic fracture incidence in elderly men
and women: the Dubbo Osteoporosis Epidemiology Study
(DOES). Osteoporos Int 1994; 4: 277–82.
4. Melton LJ III, Crowson CS, O’Fallon WM. Fracture incidence
in Olmsted County, Minnesota: comparison of urban with
rural rates and changes in urban rates over time. Osteoporos
Int 1999; 9: 29–37.
5. O’Neill TW, Roy DK. How many people develop fractures
with what outcome? Best Pract Res Clin Rheumatol 2005; 19:
879–95.
6. Johnell O, Kanis JA. An estimate of the worldwide prevalence
and disability associated with osteoporotic fractures.
Osteoporos Int 2006; 17: 1726–33.
7. Kanis JA, Johnell O, Oden A et al.. Long-term risk of osteo-
porotic fracture in Malmo. Osteoporos Int 2000; 11: 669–74.
8. Sakuma M, Endo N, Oinuma T et al.. Incidence and outcome
of osteoporotic fractures in 2004 in Sado City, Niigata
Prefecture, Japan. J Bone Miner Metab 2008; 26: 373–8.
9. Majumdar SR, Kim N, Colman I et al.. Incidental vertebral
fractures discovered with chest radiography in the emergency
department: prevalence, recognition, and osteoporosis man-
agement in a cohort of elderly patients. Arch Intern Med
2005; 165: 905–9.
10. Strom O, Borgstrom F, Zethraeus N et al.. Long-term cost
and effect on quality of life of osteoporosis-related fractures
in Sweden. Acta Orthop 2008; 79: 269–80.
11. Bouza C, Lopez T, Palma M, Amate JM. Hospitalised osteo-
porotic vertebral fractures in Spain: analysis of the national
hospital discharge registry. Osteoporos Int 2007; 18: 649–57.
12. Puffer S, Torgerson DJ, Sykes D, Brown P, Cooper C. Health
care costs of women with symptomatic vertebral fractures.
Bone 2004; 35: 383–6.
13. Harris TB, Launer LJ, Eiriksdottir G et al.. Age, Gene/
Environment Susceptibility-Reykjavik Study: multidisciplinary
applied phenomics. Am J Epidemiol 2007; 165: 1076–87.
14. Bjornsson O, Davidsson D, Olafsson H et al. Report ABC
XVIII Health Survey in the Reykjavik Area—Men Stages
I–III 1967–1969 1970–1971 and 1974–1976 Participants
Invitation Response etc. Reykjavik: The Icelandic Heart
Association, 1979.
15. Bjornsson G, Bjornsson O, Davidsson D et al. Report abc
XXIV Health Survey in the Reykjavik Area—Women Stages
I–III 1968–1969 1971–1972 and 1976–1978 Participants
Invitation Response etc. Reykjavik: Icelandic Heart
Association, 1982.
16. Siggeirsdottir K, Aspelund T, Sigurdsson G et al.. Inaccuracy
in self-report of fractures may underestimate association with
health outcomes when compared with medical record based
fracture registry. Eur J Epidemiol 2007; 22: 631–9.
17. EuroQol—a new facility for the measurement of
health-related quality of life. The EuroQol Group. Health
Policy 1990; 16: 199–208.
18. Podsiadlo D, Richardson S. The timed ‘Up & Go’: a test of
basic functional mobility for frail elderly persons. J Am
Geriatr Soc 1991; 39: 142–8.
19. Siggeirsdottir K, Jonsson BY, Jonsson H Jr, Iwarsson S. The
timed ‘Up & Go’ is dependent on chair type. Clin Rehabil
2002; 16: 609–16.
20. Ostir GV, Markides KS, Black SA, Goodwin JS. Lower body
functioning as a predictor of subsequent disability among
older Mexican Americans. J Gerontol A Biol Sci Med Sci
1998; 53: M491–5.
21. Era P. Maximal isometric muscle strength and anthropometry
in 75-year-old men and women in three Nordic localities.
Scand J Med Sci Sports 1994; 4: 26–31.
22. Armitage JN, van der Meulen JH. Identifying co-morbidity in
surgical patients using administrative data with the Royal College
of Surgeons Charlson Score. Br J Surg 97 2010; 772–81.
23. Kanis JA, Johnell O, Oden A et al.. The risk and burden of
vertebral fractures in Sweden. Osteoporos Int 2004; 15:
20–6.
24. Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman
JA. Mortality after all major types of osteoporotic fracture in
men and women: an observational study. Lancet 1999; 353:
878–82.
25. Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA,
Center JR. Mortality risk associated with low-trauma osteo-
porotic fracture and subsequent fracture in men and women.
JAMA 2009; 301: 513–21.
26. Stel VS, Pluijm SM, Deeg DJ, Smit JH, Bouter LM, Lips P.
Functional limitations and poor physical performance as in-
dependent risk factors for self-reported fractures in older
persons. Osteoporos Int 2004; 15: 742–50.
27. Ganz SB, Peterson MG, Russo PW, Guccione A. Functional
recovery after hip fracture in the subacute setting. Hss J
2007; 3: 50–7.
28. Wust RC, Morse CI, de Haan A, Jones DA, Degens H. Sex
differences in contractile properties and fatigue resistance of
human skeletal muscle. Exp Physiol 2008; 93: 843–50.
29. Kirchengast S, Haslinger B. Gender differences in
health-related quality of life among healthy aged and old-aged
Austrians: cross-sectional analysis. Gend Med 2008; 5: 270–8.
30. Nevitt MC, Thompson DE, Black DM et al.. Effect of alen-
dronate on limited-activity days and bed-disability days
caused by back pain in postmenopausal women with existing
vertebral fractures. Fracture Intervention Trial Research
Group. Arch Intern Med 2000; 160: 77–85.
Received 14 June 2011; accepted in revised form
3 October 2011
357
Effect of vertebral fractures on function
